128 related articles for article (PubMed ID: 26891237)
41. Amplification and sequencing of varicella-zoster virus (VZV) gene 4: point mutation in a VZV strain causing chickenpox during pregnancy.
Chow VT; Lim KP
Acta Virol; 1997 Oct; 41(5):277-83. PubMed ID: 9607081
[TBL] [Abstract][Full Text] [Related]
42. RNA-seq analysis of host and viral gene expression highlights interaction between varicella zoster virus and keratinocyte differentiation.
Jones M; Dry IR; Frampton D; Singh M; Kanda RK; Yee MB; Kellam P; Hollinshead M; Kinchington PR; O'Toole EA; Breuer J
PLoS Pathog; 2014 Jan; 10(1):e1003896. PubMed ID: 24497829
[TBL] [Abstract][Full Text] [Related]
43. Varicella-zoster virus infection of a human CD4-positive T-cell line.
Zerboni L; Sommer M; Ware CF; Arvin AM
Virology; 2000 May; 270(2):278-85. PubMed ID: 10792986
[TBL] [Abstract][Full Text] [Related]
44. Development of Robust Varicella Zoster Virus Luciferase Reporter Viruses for In Vivo Monitoring of Virus Growth and Its Antiviral Inhibition in Culture, Skin, and Humanized Mice.
Lloyd MG; Yee MB; Flot JS; Liu D; Geiler BW; Kinchington PR; Moffat JF
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458556
[TBL] [Abstract][Full Text] [Related]
45. Neuronal changes induced by Varicella Zoster Virus in a rat model of postherpetic neuralgia.
Guedon JM; Yee MB; Zhang M; Harvey SA; Goins WF; Kinchington PR
Virology; 2015 Aug; 482():167-80. PubMed ID: 25880108
[TBL] [Abstract][Full Text] [Related]
46. Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis.
Sen N; Che X; Rajamani J; Zerboni L; Sung P; Ptacek J; Arvin AM
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):600-5. PubMed ID: 22190485
[TBL] [Abstract][Full Text] [Related]
47. Latency and reactivation of varicella zoster virus infections.
Dueland AN
Scand J Infect Dis Suppl; 1996; 100():46-50. PubMed ID: 9163025
[TBL] [Abstract][Full Text] [Related]
48. Varicella zoster virus immune evasion strategies.
Abendroth A; Kinchington PR; Slobedman B
Curr Top Microbiol Immunol; 2010; 342():155-71. PubMed ID: 20563710
[TBL] [Abstract][Full Text] [Related]
49. Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells.
Moffat J; Ito H; Sommer M; Taylor S; Arvin AM
J Virol; 2002 Aug; 76(16):8468-71. PubMed ID: 12134050
[TBL] [Abstract][Full Text] [Related]
50. Simian varicella: a model for human varicella-zoster virus infections.
Gray WL
Rev Med Virol; 2004; 14(6):363-81. PubMed ID: 15386593
[TBL] [Abstract][Full Text] [Related]
51. Experimental infection of Cynomolgus Macaques (Macaca fascicularis) with human varicella-zoster virus.
Willer DO; Ambagala AP; Pilon R; Chan JK; Fournier J; Brooks J; Sandstrom P; Macdonald KS
J Virol; 2012 Apr; 86(7):3626-34. PubMed ID: 22258257
[TBL] [Abstract][Full Text] [Related]
52. Sequence analysis of the leftward end of simian varicella virus (EcoRI-I fragment) reveals the presence of an 8-bp repeat flanking the unique long segment and an 881-bp open-reading frame that is absent in the varicella zoster virus genome.
Mahalingam R; White T; Wellish M; Gilden DH; Soike K; Gray WL
Virology; 2000 Sep; 274(2):420-8. PubMed ID: 10964784
[TBL] [Abstract][Full Text] [Related]
53. Advances in the treatment of varicella-zoster virus infections.
Andrei G; Snoeck R
Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
[TBL] [Abstract][Full Text] [Related]
54. Varicella-Zoster virus proteins encoded by open reading frames 14 and 67 are both dispensable for the establishment of latency in a rat model.
Grinfeld E; Sadzot-Delvaux C; Kennedy PG
Virology; 2004 May; 323(1):85-90. PubMed ID: 15165821
[TBL] [Abstract][Full Text] [Related]
55. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
[TBL] [Abstract][Full Text] [Related]
56. Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo.
Jones JO; Arvin AM
J Virol; 2003 Jan; 77(2):1268-80. PubMed ID: 12502844
[TBL] [Abstract][Full Text] [Related]
57. Varicella-Zoster virus gene expression at variable periods following death in a rat model of ganglionic infection.
Grinfeld E; Goodwin R; Kennedy PG
Virus Genes; 2007 Aug; 35(1):29-32. PubMed ID: 17039406
[TBL] [Abstract][Full Text] [Related]
58. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse.
Moffat JF; Zerboni L; Sommer MH; Heineman TC; Cohen JI; Kaneshima H; Arvin AM
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11969-74. PubMed ID: 9751774
[TBL] [Abstract][Full Text] [Related]
59. Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice.
Rowe J; Greenblatt RJ; Liu D; Moffat JF
Antiviral Res; 2010 Jun; 86(3):276-85. PubMed ID: 20307580
[TBL] [Abstract][Full Text] [Related]
60. Three-dimensional normal human neural progenitor tissue-like assemblies: a model of persistent varicella-zoster virus infection.
Goodwin TJ; McCarthy M; Osterrieder N; Cohrs RJ; Kaufer BB
PLoS Pathog; 2013; 9(8):e1003512. PubMed ID: 23935496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
